# A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

> **NCT00129623** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 160 (actual)

## Conditions studied

- Post-Menopausal Osteopenia

## Interventions

- **DRUG:** Placebo
- **DRUG:** ibandronate [Bonviva/Boniva]

## Key facts

- **NCT ID:** NCT00129623
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2016-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129623, "A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00129623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*